A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
Response to Comment on "SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML"
2016
Science Signaling
Preserved Fulltext
Arsenic trioxide chemotherapy cures acute promyelocytic leukemia by inducing the ubiquitylation of an oncogenic fusion protein containing promyelocytic leukemia protein (PML) subsequent to modification of PML by SUMO1 and SUMO2. We proposed that the SUMO switch at Lys 65 of PML enhanced subsequent SUMO2 conjugation to Lys 160 and consequent RNF4-dependent ubiquitylation of PML. Ferhi et al. note differences between their experimental system and ours regarding the outcome and mechanisms of
doi:10.1126/scisignal.aad9777
pmid:27507652
fatcat:6y3secucp5ecrlh35oqt4jwhsy